Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Competition SESN

<< Previous

Bullboard Posts

Next >>

Comment by robertshawon Dec 09, 2021 1:17pm

524 Views

Post# 34215202

RE:Competition SESN

enriquesuave wrote: Sessen Bio was told by the FDA that a new trial would be needed before they can resubmit their BLA application. They are asking for a randomized clinical trial against intravesicle chemotherapy. Feel sorry for the shareholders. Their efficacy was not up to par IMHO.

Blowjobjoe's bosses are idiots for not shorting SESN but heavily naked shorting on us

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec